TAMMY SMITH: Open Payments
NPI 1720006315 · GREENWELL SPRINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 31 payments from 8 companies in 2025. Trend: 2023 $40 · 2024 $0 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $177 |
| ABBVIE INC. | 10 | $153 |
| Lilly USA, LLC | 7 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Dexcom, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Ozempic, MOUNJARO, VRAYLAR, QULIPTA, CAPLYTA, Dexcom G6 Transmitter, Rybelsus, XIFAXAN.
Industry payments across LA — which companies pay providers there.
